News & Updates
Discover the latest Cutting-Edge Proteomic news, annoucements, and insights from KPL.
KPL ApS to attend The Proteomics Revolution 2026 (SEMM Workshop) in Milan, Italy
COPENHAGEN, Denmark, June 29, 2026 – KPL ApS, a wholly owned subsidiary of Genovis AB, at the forefront of advancing proteomics and protein engineering, is participating in the SEMM Workshop “The Proteomics Revolution: Advancing Science and Society,” held at the Quark…
KPL ApS Announces Strategic Acquisition by Genovis AB
COPENHAGEN, Denmark, June 4, 2026 – KPL ApS, a pioneering company at the forefront of advancing proteomics and protein engineering, announces that it has entered into a strategic acquisition agreement with Genovis AB, a Swedish life science tools company listed on…
KPL ApS to Attend ASMS 2026 in San Diego, California
COPENHAGEN, Denmark, May 29, 2026 – KPL ApS, a pioneering company at the forefront of advancing proteomics and protein engineering, will be participating in the 74th ASMS Conference on Mass Spectrometry and Allied Topics, to be held in San Diego, California, May 31 –…
KPL researchers publish bioRxiv preprint characterizing a high-fidelity recombinant arginyl endopeptidase Arg-C Zero for mass spectrometry-based proteomics
COPENHAGEN, Denmark, May 29, 2026 – KPL ApS, a pioneering company focused on advancing proteomics and protein engineering, announces the publication of research characterizing Arg-C Zero, KPL’s recombinant arginyl endopeptidase derived from Porphyromonas gingivalis…
KPL ApS to Exhibit and Attend at ESAC 2026 in Copenhagen
COPENHAGEN, Denmark, March 12, 2026 – KPL ApS, a pioneering company at the forefront of advancing proteomics and protein engineering, is participating as a vendor exhibitor at the 25th Annual Executive Seminars in Analytical Chemistry (ESAC 2026), held today at…
KPL ApS to Present Latest R&D at the 2026 Finnish Proteomics Symposium in Espoo, Finland
COPENHAGEN, Denmark, March 12, 2026 – KPL ApS, a pioneering company at the forefront of advancing proteomics and protein engineering, will be participating in the 2026 Finnish Proteomics Symposium (FinnProt) held at Hotel Nuuksio in Espoo, Finland on March 12-13,…
KPL ApS awarded prestigious EUROSTARS grant
COPENHAGEN, Denmark, 25 February, 2026 – KPL ApS is proud to announce that it has been awarded the EUROSTARS grant under EUROSTARS-3 Call 9, in a collaborative project with our partner ReSyn Biosciences. This prestigious competitive grant is funded through the…
KPL ApS Launches Trypsin/Lys-C Premium Mix
COPENHAGEN, Denmark, 17 February, 2026 – KPL ApS announces the launch of the Trypsin/Lys-C Premium Mix [KPL0209], a ready-to-use enzyme blend combining our recombinant Trypsin RMS and sequencing-grade Lys-C for mass spectrometry-based proteomics. The newest addition…
KPL ApS Launches Trypsin RMS
COPENHAGEN, Denmark, 02 February, 2026 – KPL ApS is proud to announce the launch of Trypsin RMS (KPL0208), a recombinant, reductively methylated, sequencing-grade Trypsin for mass spectrometry-based proteomics. The third product in KPL’s expanding portfolio of…
KPL Collaborates on First Systematic Comparison of LysC Enzymes
COPENHAGEN, Denmark, January 13, 2026 – A comprehensive new study published in the Journal of Proteome Research, co-authored by KPL’s scientific team, provides the first systematic comparison of the three main LysC homologues used in mass spectrometry-based…